Ontogeny of human brain dopamine receptors I. Differential expression of [3H]-SCH23390 and [3H]-YM09151-2 specific binding

Developmental Brain Research

Volumn 106, Issue 1-2, 1998, Pages 109-117

  Unis, Alan S ^a   Roberson, Michael D ^a   Robinette, Renee ^a   Ha, James ^a   Dorsa, Daniel M ^a  

^a NONE

Author keywords

Cortex; Dopamine or dopaminergic; Fetal brain development or ontogeny; Forebrain; Neuronal differentiation; Neurotransmitter receptor; Striatum

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; EMONAPRIDE; TRITIUM;

ARTICLE; BRAIN DEVELOPMENT; COGNITION; DRUG RECEPTOR BINDING; FETUS; FOREBRAIN; HUMAN; HUMAN TISSUE; ONTOGENY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR AFFINITY; RECEPTOR DENSITY;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; AUTORADIOGRAPHY; BENZAMIDES; BRAIN; CEREBRAL CORTEX; CORPUS STRIATUM; EMBRYONIC AND FETAL DEVELOPMENT; FEMALE; GESTATIONAL AGE; HUMANS; MALE; PROSENCEPHALON; RADIOLIGAND ASSAY; RECEPTORS, DOPAMINE; TRITIUM;

ANIMALIA; TRITIUM;

EID: 0031981257     PISSN: 01653806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-3806(97)00202-2     Document Type: Article

References (17)

1. Baskin D.G., Filuk P.E., Stahl W.L. Standardization of tritium-sensitive film for quantitative autoradiography. J. Histochem. Cytochem. 37(9):1989;1337-1344.
2. 1 dopamine receptors after neonatal 6-hydroxydopamine treatment: relevance to Lesch-Nyan disease. Adv. Exp. Med. Biol. 204:1986;197-215.
3. Feigenbaum J.J., Yanai J. Normal and abnormal determinants of dopamine receptor ontogeny in the central nervous system. Prog. Neurobiol. 23:1984;191-225.
4. Gerfen C.R. The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia. Annu. Rev. Neurosci. 15:1992;285-320.
5. K.E. Guire, C.J. Kowalski, Mathematical description and representation of developmental change functions on the intra and interindividual levels, in: J.R. Nesselroad, P.B. Baltes (Eds.), Longitudinal Research in the Study of Behavior and Development, Academic Press, New York, pp. 89-110.
6. Huang Y.Y., Kandel E.R. D1/D5 receptor agonists induce a protein synthesis-dependent late potentiation in the CA1 region of the hippocampus. Proc. Natl. Acad. Sci. USA. 92:1995;2446-2450.
7. 1 antagonist. Eur. J. Pharm. 91:1983;153-154.
8. D.J. Koerker, I.R. Sweet, D.G. Baskin, Insulin binding to individual rat skeletal muscles, American Physiological Society, 1990, E517-E523.
9. P.J. Munson, D. Rodbard, A User's Guide to Ligand: Data analysis and curve-fitting for ligand binding experiments. Laboratory of Theoretical and Physical Biology, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD. May 1987, Reprinted October 1988.
10. 1 receptor development in the rat striatum: early localization in striosomes. Brain Res. 480:1989;170-177.
11. 2 receptors. Synapse. 11:1992;35-46.
12. Olsen L., Boréus O., Seiger Å. Histochemical demonstration and mapping of 5-hydroxytryptamine- and catecholamine-containing neuron systems in the human fetal brain. Z. Anat. Entwick-Gech. 139:1973;259-282.
13. Ramm P. Low-cost computer-assisted densitometry for autoradiography: a practical guide to systems costing less than US$10,000. Soc. Neurosci. Abstr. 11:1985;1087.
14. 4 dopamine receptors in transfected neuronal cell lines. Proc. Natl. Acad. Sci. USA. 91:1994;649-653.
15. 2 receptors. Life Sci. 47:1991;PL151-PL155.
16. A.S. Unis, Developmental molecular psychopharmacology in early-onset psychiatric disorder: from models to mechanisms, Child and Adolescent Psychiatric Clinics in North America, 4 (1) 1995, pp. 41-57.
17. 3H-Ultrofilm: application to multiple benzodiazepine receptors. J. Neurosci. Meth. 6:1982;59.